https://msni.it/members/newest&amp?offset=690 https://msni.it/profile/Camilla Wed, 19 Dec 2012 11:11:24 +0100 https://msni.it/profile/Camilla https://msni.it/profile/Alex_Frou Sun, 16 Dec 2012 00:15:13 +0100 https://msni.it/profile/Alex_Frou https://msni.it/profile/grifonewalter Fri, 14 Dec 2012 23:24:32 +0100 https://msni.it/profile/grifonewalter https://msni.it/profile/salmonerosso Fri, 14 Dec 2012 16:24:15 +0100 https://msni.it/profile/salmonerosso https://msni.it/profile/Molmed Wed, 12 Dec 2012 20:34:11 +0100 https://msni.it/profile/Molmed MolMed S.p.A. è un’azienda biotecnologica focalizzata su ricerca, sviluppo e validazione clinica di terapie innovative per la cura del cancro. Il portafoglio-prodotti di MolMed comprende due terapeutici antitumorali entrambi in sperimentazione clinica di Fase III. Le azioni di MolMed sono quotate al segmento Standard (classe I) del MTA gestito da Borsa Italiana (Ticker Reuters: MLMD.MI).

]]> https://msni.it/profile/stefano_ Tue, 11 Dec 2012 14:51:23 +0100 https://msni.it/profile/stefano_ https://msni.it/profile/brujo71 Mon, 10 Dec 2012 17:55:24 +0100 https://msni.it/profile/brujo71 https://msni.it/profile/nixniko Sat, 08 Dec 2012 01:58:50 +0100 https://msni.it/profile/nixniko https://msni.it/profile/abner Fri, 07 Dec 2012 00:25:59 +0100 https://msni.it/profile/abner https://msni.it/profile/damiano_79 Thu, 06 Dec 2012 19:54:56 +0100 https://msni.it/profile/damiano_79